bio89-100
89bio
['pegozafermin', 'cardio']
session &amp; expo together with world congress of cardiology (acc.23/wcc). data showed pegozafermin treatment was found to be effective in reducing triglycerides and other atherogenic lipids in patients with shtg, regardless of their existing lipid-modifying therapy. 3
xwz